##### ยง 558.330 Lubabegron. #####

(a) *Specifications.* Each pound of Type A medicated article contains 4.54 grams (10 grams per kilogram) of lubabegron as lubabegron fumarate.

(b) *Sponsor.* See No. 058198 in ยง 510.600(c) of this chapter.

(c) *Related tolerances.* See ยง 556.370 of this chapter.

(d) *Conditions of use.* It is used in cattle feed as follows:

|Lubabegron  <br/>grams/ton|Combination in grams/ton|                                                                                  Indications for use                                                                                  |                                                                                                                                                                  Limitations                                                                                                                                                                  |Sponsors|
|--------------------------|------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
|     (1) 1.25 to 4.54     |                        |Beef steers and heifers fed in confinement for slaughter: For reduction of ammonia gas emissions per pound of live weight and hot carcass weight during the last 14 to 91 days on feed.|Feed 1.25 to 4.54 g/ton (1.39 to 5 ppm) of complete feed (90% dry matter basis) to provide 13 to 90 milligrams lubabegron/head/day continuously. Do not allow horses or other equines access to feed containing lubabegron. Not approved for use in breeding animals because safety and effectiveness have not been evaluated in these animals.| 058198 |
|      (i) [Reserved]      |                        |                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                               |        |
|     (ii) [Reserved]      |                        |                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                               |        |
|      (2) [Reserved]      |                        |                                                                                                                                                                                       |                                                                                                                                                                                                                                                                                                                                               |        |

[84 FR 12501, Apr. 2, 2019]